Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

Kuwahara Taishi; Abe Mitsunori; Yamaki Masaru; Fujieda Hiroyuki; Abe Yumiko; Hashimoto Katsushi; Ishiba Misako; Sakai Hirotsuka; Hishikari Keiichi; Takigawa Masateru; Okubo Kenji; Takagi Katsumasa; Tanaka Yasuaki; Nakajima Jun; Takahashi Atsushi

首页> 外文期刊>Journal of cardiovascular electrophysiology >Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

【24h】

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

机译：阿哌沙班与华法林预防房颤消融术中脑血栓栓塞的预防：多中心前瞻性随机研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Apixaban Thromboembolism Prevention in AF Ablation. Introduction: Stroke can be a life-threatening complication of atrial fibrillation (AF) catheter ablation. Uninterrupted warfarin treatment contributes to minimizing the risk of stroke complications.

机译：房颤消融术中阿哌沙班预防血栓栓塞。简介：中风可能是威胁心房纤颤（AF）导管消融的并发症。不间断的华法林治疗有助于将中风并发症的风险降至最低。

著录项

来源
《Journal of cardiovascular electrophysiology》 |2016年第5期|共6页
作者
Kuwahara Taishi; Abe Mitsunori; Yamaki Masaru; Fujieda Hiroyuki; Abe Yumiko; Hashimoto Katsushi; Ishiba Misako; Sakai Hirotsuka; Hishikari Keiichi; Takigawa Masateru; Okubo Kenji; Takagi Katsumasa; Tanaka Yasuaki; Nakajima Jun; Takahashi Atsushi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类人体生理学;
关键词
anticoagulant; apixaban; atrial fibrillation; catheter ablation; silent cerebral infarction; stroke; warfarin;

机译：抗凝剂;阿哌沙班;心房纤颤;导管消融;静默性脑梗死;中风;华法林;

相似文献

外文文献
中文文献
专利

1. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study [J] . Kuwahara Taishi, Abe Mitsunori, Yamaki Masaru, Journal of cardiovascular electrophysiology . 2016,第5期

机译：阿哌沙班与华法林预防房颤消融术中脑血栓栓塞的预防：多中心前瞻性随机研究
2. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry [J] . LakkireddyD., ReddyY.M., DiBiaseL., Journal of the American College of Cardiology . 2012,第13期

机译：达比加群与华法林联合射频消融治疗房颤的围手术期抗凝的可行性和安全性：多中心前瞻性研究的结果
3. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperati [J] . Yamaguchi T Stroke: A Journal of Cerebral Circulation . 2000,第4期

机译：华法林用于非瓣膜性房颤患者继发性卒中的最佳治疗强度：一项多中心，前瞻性，随机试验。日本非瓣膜性心房颤动-代谢二级预防合作社
4. Evaluation of compliance with recommendations of prevention of thromboembolism in atrial fibrillation in the elderly, by data reuse of electronic health records [C] . Laurie FERRET, Jean-Baptiste BEUSCART, Gregoire FICHEUR, Medical Informatics in Europe Conference. . 2015

机译：通过电子健康记录的数据重用评估遵守预防老年心房颤动的血栓栓塞建议的建议
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
7. Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation Results From a Multicenter Prospective Registry [O] . Lakkireddy Dhanunjaya, Reddy Yeruva Madhu, Di Biase Luigi, 2012

机译：达比加群对华法林与华法林在多中心前瞻性登记中心进行射频消融治疗房颤的患者围手术期抗凝的可行性和安全性

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study

摘要

著录项

相似文献

相关主题

期刊订阅